Veterinary Medicines

AVIFFA RTI lyofilizát na suspenziu pre kurčatá a morky

Authorised
  • Turkey rhinotracheitis virus, strain VCO3, Live
Download as PDF

Product identification

Medicine name:
AVIFFA RTI lyofilizát na suspenziu pre kurčatá a morky
Active substance:
  • Turkey rhinotracheitis virus, strain VCO3, Live
Target species:
  • Chicken
  • Turkey
Route of administration:
  • In drinking water use
  • Oculonasal use
  • Nebulisation use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain VCO3, Live
    4.00
    log10 cell culture infective dose 50/millilitre
    /
    50.00
    microlitre(s)
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • All relevant tissues
        0
        day
    • Turkey
  • Oculonasal use
    • Chicken
      • All relevant tissues
        0
        day
    • Turkey
  • Nebulisation use
    • Turkey
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
  • QI01CD01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/0098/97-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 18/07/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."